Graf Akcie OCUL (Ocular Therapeutix Inc). Diskuze k akciím OCUL. Aktuální informace OCUL.

Základní informace o společnosti Ocular Therapeutix Inc (Akcie OCUL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 880.41M
Hodnota podniku (EV) N/A
Tržby 32.285M
EBITDA N/A
Zisk -102.92
Růst v tržbách Q/Q 646.85 %
Růst v tržbách Y/Y 344.51 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.14
EV/Sales 18.97
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 27.27
P/FCF N/A
Price/Book 11.57
Účetní hodnota na akcii 0.97
Hotovost na akcii 2.92
FCF vůči ceně -6.60 %
Počet zaměstnanců 181
Tržba na zaměstnance 178.370k
Profit margin -894.31 %
Operating margin -213.13 %
Gross margin 88.03 %
EBIT margin -297.79 %
EBITDA margin -676.46 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -82.81 %
EPS - Očekávaný růst příští rok 19.05 %
Return on assets -49.37 %
Return on equity -174.71 %
ROIC -87.41 %
ROCE -45.97 %
Dluhy/Equity 2.44
Čistý dluh/EBITDA 0.31
Current ratio 10.05
Quick Ratio 10.00
Volatilita 5.85
Beta 1.29
RSI 55.03
Cílová cena analytiků 16
Známka akcie (dle analytiků) 1.33
Insider ownership 0.39 %
Institutional ownership 64.87 %
Počet akcií 76.583M
Procento shortovaných akcií 8.38 %
Short ratio 7.17 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie OCUL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$4.227$1.99$1.923$1.887$1.75$0.772-$0.01
Cost Of Goods Sold$2.325$0.465$0.457$0.443$0.319$0.091-$0.007
Gross Profit$1.902$1.525$1.466$1.444$1.431$0.681-$0.003
Research And Development Expenses$41.091$36.915$30.88$27.065$26.611$18.88$10.517$11.54
SG&A Expenses$46.613$23.728$32.509$17.705$13.017$8.895$2.386$2.134
Other Operating Income Or Expenses--------
Operating Expenses$90.029$61.108$63.846$45.213$39.947$27.866$12.903$13.681
Operating Income$-85.802$-59.118$-61.923$-43.326$-38.197$-27.094$-12.903$-13.671
Total Non-Operating Income/Expense$-0.57$-0.86$-1.463$-1.377$-1.551$-1.554$-0.414$-0.422
Pre-Tax Income$-86.372$-59.978$-63.386$-44.703$-39.748$-28.648$-13.317$-14.093
Income Taxes--------
Income After Taxes$-86.372$-59.978$-63.386$-44.703$-39.748$-28.648$-13.317$-14.093
Other Income--------
Income From Continuous Operations$-86.372$-59.978$-63.386$-44.703$-39.748$-28.648$-13.317$-14.093
Income From Discontinued Operations--------
Net Income$-86.372$-59.978$-63.386$-44.703$-39.748$-28.659$-13.344$-14.128
EBITDA$-83.272$-56.832$-60.281$-42.259$-37.16$-26.523$-12.499$-13.267
EBIT$-85.802$-59.118$-61.923$-43.326$-38.197$-27.094$-12.903$-13.671
Basic Shares Outstanding45382925231133
Shares Outstanding45382925231133
Basic EPS$-1.91$-1.57$-2.20$-1.80$-1.71$-2.69$-5.11$-5.60
EPS - Earnings Per Share$-1.91$-1.57$-2.20$-1.80$-1.71$-2.69$-5.11$-5.60
# 2020 2019 2018 2017 2016 2015
Current Ratio5.00216.13533.2288.421419.892712.9695
Long-term Debt / Capital1.07950.40860.32290.21320.14560.1871
Debt/Equity Ratio-13.58460.6910.6890.30080.17050.2533
Gross Margin44.996576.633276.235176.523681.771488.2124
Operating Margin-2029.856-2970.754-3220.125-2296.025-2182.686-3509.585
EBIT Margin-2029.856-2970.754-3220.125-2296.025-2182.686-3509.585
EBITDA Margin-1970.002-2855.879-3134.738-2239.48-2123.428-3435.622
Pre-Tax Profit Margin-2043.34-3013.97-3296.204-2368.998-2271.314-3710.881
Net Profit Margin-2043.34-3013.97-3296.204-2368.998-2271.314-3712.306
Asset Turnover0.05370.02720.03470.02520.01590.0099
Inventory Turnover Ratio2.43712.14293.74593.92042.38060.6842
Receiveable Turnover1.65899.90058.50887.5489.06742.3465
Days Sales In Receivables220.018936.866842.896548.357240.2543155.5505
ROE - Return On Equity2379.411-167.1861-242.4218-85.9541-44.3675-48.8074
Return On Tangible Equity2379.391-167.1861-242.4217-85.9541-44.3676-48.8074
ROA - Return On Assets-109.6927-82.1133-114.3512-59.6525-36.0343-36.6376
ROI - Return On Investment-189.0723-98.8708-164.1359-67.6273-37.9058-39.6748
Book Value Per Share-0.07210.86410.88162.07833.61972.7513
Operating Cash Flow Per Share-0.42210.4599-0.38130.08160.47232.9227
Free Cash Flow Per Share-0.42190.6965-0.59020.08050.51432.9528

Porovnání s konkurencí: Akcie OCUL

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie ANIK N/A 3.19 8.98 % -53.33 % -4.53 % 2.17 -18.38 %
Akcie HAE 55.05 2.20 -4.46 % -1.61 % 9.23 % 4.87 9.13 %
Akcie SRDX 507.18 4.00 0.55 % 38.89 % 1.15 % 5.81 1.18 %
Akcie XENT 0.00 N/A 20.15 % 22.86 % -112.75 % 13.46 -89.78 %

Nedávné obchody insiderů: Akcie OCUL

Jméno Obchod Cena Objem
Amarpreet Sawhney
President and CEO
Nákup
6 Jun 2019
$2.92 $363,447
Leslie J. Williams
Director
Nákup
14 Jun 2019
$4.40 $19,800
Donald Notman
Chief Financial Officer
Nákup
14 Jun 2019
$4.33 $10,825
Management Inc. Opaleye
Nákup
30 Dec 2019
$3.97 $79,400
Management Inc. Opaleye
Nákup
2 Jan 2020
$3.90 $58,500
Road Llc Summer
10% owner
Nákup
13 Mar 2020
$4.55 $4,345,532
Road Llc Summer
10% owner
Nákup
18 Mar 2020
$4.62 $1,782,572
Road Llc Summer
10% owner
Nákup
20 Mar 2020
$4.71 $513,861
Road Llc Summer
10% owner
Nákup
19 May 2020
$5.50 $1,999,998
Road Llc Summer
10% owner
Nákup
16 Oct 2020
$10.48 $4,580
Bruce Peacock
Director
Option
3 Dec 2020
$5.09 $127,250

Diskuze k akciím OCUL